Ssr Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.30 M
as on 06-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2017)
- Profit 76.41%
(FY 2017)
- Ebitda 76.41%
(FY 2017)
- Net Worth -2.53%
(FY 2017)
- Total Assets 27925.16%
(FY 2017)
About Ssr Pharma
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.30 M, as per Ministry of Corporate Affairs (MCA) records.
Lajju Rauthan, Surjan Rauthan, and Sandeepkumar Agarwal serve as directors at the Company.
- CIN/LLPIN
U24233MH2005PTC150848
- Company No.
150848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jan 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Ssr Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surjan Rauthan  | Director | 25-Jan-2008 | Current |
| Lajju Rauthan | Director | 25-Jan-2008 | Current |
| Sandeepkumar Agarwal | Director | 13-Jun-2016 | Current |
Financial Performance and Corporate Structure Insights of Ssr Pharma.
Ssr Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 76.41% increase in profit. The company's net worth dipped by a decrease of 2.53%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssr Pharma?
In 2017, Ssr Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shree Aniruddha Motors Private LimitedActive 37 years 6 monthsLajju Rauthan and Surjan Rauthan are mutual person
- Sambhav Investments And Trading Company Private LimitedActive 32 years 6 months
Lajju Rauthan and Surjan Rauthan are mutual person
- Ssr Corporate Associates Private LimitedActive 17 years 8 months
Lajju Rauthan and Surjan Rauthan are mutual person
- Rkg Healthcare Private LimitedActive 14 years 6 months
Lajju Rauthan and Surjan Rauthan are mutual person
- Surya Arts Private LimitedActive 21 years 3 months
Lajju Rauthan and Surjan Rauthan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ssr Pharma?
Unlock and access historical data on people associated with Ssr Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssr Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssr Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
